Edition:
United Kingdom

Collegium Pharmaceutical Inc (COLL.OQ)

COLL.OQ on NASDAQ Stock Exchange Global Select Market

24.50USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$24.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
199,033
52-wk High
$26.73
52-wk Low
$7.37

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.69 December 22 Feb 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 4 4 4 4
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.57 1.57 1.57 1.57

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 4 58.68 70.80 44.41 29.30
Quarter Ending Jun-18 4 70.33 77.40 61.11 34.70
Year Ending Dec-18 6 293.93 311.99 251.06 90.82
Earnings (per share)
Quarter Ending Mar-18 4 -0.69 -0.27 -1.36 -0.21
Quarter Ending Jun-18 4 -0.29 -0.10 -0.50 0.03
Year Ending Dec-18 6 -0.82 -0.10 -1.71 -1.26

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 5.36 11.95 6.59 122.74
Quarter Ending Jun-17 3.64 3.56 0.08 2.10
Quarter Ending Mar-17 3.57 2.17 1.40 39.23
Quarter Ending Dec-16 1.66 1.30 0.36 21.45
Quarter Ending Sep-16 1.22 0.41 0.81 66.61

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 58.68 58.68 40.07 30.88 29.30
Quarter Ending Jun-18 70.33 70.33 77.02 56.01 34.70
Year Ending Dec-18 293.93 293.93 285.96 211.83 90.82

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 1 1
Quarter Ending Jun-18 0 0 1 1
Year Ending Dec-18 0 0 3 1
Earnings